# US 2012/0252080 A1 · Metabolic pathway targeting by transcription factor overexpression

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252080 A1
- Document ID: US20120252080A1
- Status: Published application
- Kind: A1
- Application number: 13/435,315
- Filed: 2012-03-30
- Published: 2012-10-04
- Earliest claimed: 2011-03-31
- Assignees: ExxonMobil Research and Engineering Company
- Inventors: Jessica Kristof; Rekha Seshadri
- Web page: https://patentgrep.com/patent/US20120252080A1

## CPC

- C12P 7/64: Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C07K 14/195: from bacteria
- Y02E 50/10: Biofuels, e.g. bio-diesel
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- Y02E: REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION

## Abstract

The invention provides microorganisms such as cyanobacteria genetically engineered to express proteins that include transcription factor domains for upregulation of lipid biosynthetic pathways. In addition to expression a gene encoding a transcription factor domain protein, the recombinant microorganisms can express at least one exogenous gene that encodes a polypeptide for the production of a fatty acid, fatty acid derivative, or triglyceride. Also included are methods of producing a fatty acid, fatty acid derivative, or triglyceride using the engineered microorganisms described herein as well as nucleic acid molecules encoding novel transcription factor domain proteins.

## Claims

### Claim 1

A recombinant cyanobacterium comprising an exogenous nucleic acid molecule encoding a transcription factor domain protein, wherein the cyanobacterium produces a greater amount of at least one free fatty acid or at least one fatty acid derivative than does a cyanobacterium that does not contain an exogenous nucleic acid molecule encoding the transcription factor domain protein.

### Claim 2 (depends on 1)

The cyanobacterium of claim 1, wherein the nucleic acid sequence encodes a cyanobacterial transcription factor domain protein.

### Claim 3 (depends on 2)

The cyanobacterium of claim 2, wherein the transcription factor domain protein is a homologous protein.

### Claim 4 (depends on 1)

The cyanobacterium of claim 1, wherein the transcription factor domain protein is a heterologous protein.

### Claim 5 (depends on 1)

The cyanobacterium of claim 1, wherein the transcription factor domain protein comprises an amino acid sequence having at least about 60% sequence identity to SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:10, SEQ ID NO:12, SEQ ID NO:14, or SEQ ID NO:16.

### Claim 6 (depends on 5)

The cyanobacterium of claim 5, wherein the amino acid sequence has at least about 85% sequence identity to SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:10, SEQ ID NO:12, SEQ ID NO:14, or SEQ ID NO:16.

### Claim 7 (depends on 1)

The cyanobacterium of claim 1, wherein the exogenous nucleic acid molecule further comprises a promoter operably linked to the sequence encoding the transcription factor domain protein.

### Claim 8 (depends on 1)

The cyanobacterium of claim 1, wherein the cyanobacterium further comprises a nucleic acid molecule encoding a thioesterase and/or lipase polypeptide having lipolytic activity.

### Claim 9 (depends on 1)

The cyanobacterium of claim 1, wherein the cyanobacterium further comprises at least one additional exogenous gene, encoding a protein for the production of a fatty acid or a fatty acid derivative.

### Claim 10 (depends on 9)

The cyanobacterium of claim 9, wherein the cyanobacterium further comprises at least one additional exogenous gene encoding an enzyme selected from the group consisting of an acetyl CoA carboxylase, a ketoacyl-CoA synthase, an acyl-CoA synthetase, a fatty acyl-CoA/aldehyde reductase, an alcohol-forming fatty acyl-CoA reductase, a fatty aldehyde-forming fatty acyl-CoA reductase, an acyl-ACP reductase, a carboxylic acid reductase, a fatty aldehyde reductase, an alcohol acetyl transferase, an acyl-CoA alcohol transacylase, an acyltransferase, a wax synthase, a fatty aldehyde decarbonylase, or a fatty acid decarboxylase.

### Claim 11 (depends on 1)

The cyanobacterium of claim 1, wherein the cyanobacterium is a Agmenellum, Anabaena, Anabaenopsis, Anacystis, Aphanizomenon, Arthrospira, Asterocapsa, Borzia, Calothrix, Chamaesiphon, Chlorogloeopsis, Chroococcidiopsis, Chroococcus, Crinalium, Cyanobacterium, Cyanobium, Cyanocystis, Cyanospira, Cyanothece, Cylindrospermopsis, Cylindrospermum, Dactylococcopsis, Dermocarpella, Fischerella, Fremyella, Geitleria, Geitlerinema, Gloeobacter, Gloeocapsa, Gloeothece, Halospirulina, Iyengariella, Leptolyngbya, Limnothrix, Lyngbya, Microcoleus, Microcystis, Myxosarcina, Nodularia, Nostoc, Nostochopsis, Oscillatoria, Phormidium, Planktothrix, Pleurocapsa, Prochlorococcus, Prochloron, Prochlorothrix, Pseudanabaena, Rivularia, Schizothrix, Scytonema, Spirulina, Stanieria, Starria, Stigonema, Symploca, Synechococcus, Synechocystis, Thermosynechococcus, Tolypothrix, Trichodesmium, Tychonema or Xenococcus species.

### Claim 12 (depends on 1)

A method of producing a free fatty acid or fatty acid derivative, the method comprising culturing the recombinant cyanobacterium of claim 1 under conditions in which the nucleic acid molecule is expressed to produce at least one free fatty acid or fatty acid derivative.

### Claim 13 (depends on 12)

The method of claim 12, wherein the cyanobacterium is cultured phototrophically.

### Claim 14 (depends on 12)

The method of claim 12, wherein the amount of the fatty acid or fatty acid derivative produced is at least 10% more than the amount of the fatty acid or fatty acid derivative produced by a cyanobacterium cultured under identical conditions that does not comprises an exogenous nucleic acid molecule encoding a transcription factor domain protein, but is otherwise identical in all respects to the recombinant cyanobacterium.

### Claim 15 (depends on 12)

The method of claim 12, wherein the cyanobacterium is selected from a group consisting of Agmenellum, Anabaena, Anabaenopsis, Anacystis, Aphanizomenon, Arthrospira, Asterocapsa, Borzia, Calothrix, Chamaesiphon, Chlorogloeopsis, Chroococcidiopsis, Chroococcus, Crinalium, Cyanobacterium, Cyanobium, Cyanocystis, Cyanospira, Cyanothece, Cylindrospermopsis, Cylindrospermum, Dactylococcopsis, Dermocarpella, Fischerella, Fremyella, Geitleria, Geitlerinema, Gloeobacter, Gloeocapsa, Gloeothece, Halospirulina, Iyengariella, Leptolyngbya, Limnothrix, Lyngbya, Microcoleus, Microcystis, Myxosarcina, Nodularia, Nostoc, Nostochopsis, Oscillatoria, Phormidium, Planktothrix, Pleurocapsa, Prochlorococcus, Prochloron, Prochlorothrix, Pseudanabaena, Rivularia, Schizothrix, Scytonema, Spirulina, Stanieria, Starria, Stigonema, Symploca, Synechococcus, Synechocystis, Thermosynechococcus, Tolypothrix, Trichodesmium, Tychonema and Xenococcus.

### Claim 16 (depends on 12)

The method of claim 12, further comprising isolating at least one free fatty acid or at least one fatty acid derivative from the cyanobacteria or from the growth media.

### Claim 17

An isolated or recombinant nucleic acid molecule comprising a nucleic acid sequence encoding a polypeptide comprising an amino acid sequence having at least about 85% sequence identity to SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10, or SEQ ID NO:12.

### Claim 18 (depends on 17)

An isolated or recombinant nucleic acid molecule according to claim 17, comprising a nucleic acid sequence encoding a polypeptide comprising an amino acid sequence having at least about 95% sequence identity to SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10, SEQ ID NO:12, or SEQ ID NO:18.

### Claim 19 (depends on 17)

The isolated or recombinant nucleic acid molecule of claim 17, operably linked to an heterologous promoter.

### Claim 20 (depends on 19)

The isolated or recombinant nucleic acid molecule of claim 19, wherein the promoter is inducible.

### Claim 21 (depends on 19)

The isolated or recombinant nucleic acid molecule of claim 19, wherein the nucleic acid molecule is in an expression vector.

### Claim 22 (depends on 17)

The isolated or recombinant nucleic acid molecule of claim 17, wherein the nucleic acid molecule is in an integration vector.
